Simulation use in nursing programs has increased dramatically, and the benefits of simulation have now been demonstrated in multiple studies.
Gene targeting with adeno-associated virus (AAV) vectors has been demonstrated in multiple human cell types with maximal targeting frequencies without engineered nucleases.
The effectiveness of fluticasone propionate (FP) aqueous nasal spray in the treatment of rhinitis has been demonstrated in multiple controlled clinical studies.
Up-regulation of glycolysis has been demonstrated in multiple tumor types and is believed to originate as an adaptive response to the selective pressure of the tumor microenvironment.
Their beneficial effects have been demonstrated in multiple small animal SCI models as well as in naturally occurring SCI in canine patients.
Although the benefits of drug-eluting stents for the treatment of native coronary lesions in patients undergoing percutaneous coronary interventions have been demonstrated in multiple clinical trials, there remains concern about the risk of late stent thrombosis.
The antimitotic effect of TTFields therapy has been demonstrated in multiple cell lines when the appropriate frequency was utilized.
The ability to define cancer subtypes, recurrence of disease and response to specific therapies using DNA microarray-based gene expression signatures has been demonstrated in multiple studies.
The generation of arrays of optical traps with the use of microlens arrays and diffraction optics has been demonstrated in multiple studies [101].
Increased frequency of non-classical monocytes, in association with other markers of dyslipidemia, has been demonstrated in multiple human studies [24,62,63].
Inverse correlations of blood glucose with tumor FDG uptake have been demonstrated in multiple settings (see Figures 1 and 2, [2 6]), and this effect was to be expected based on the biochemistry of glucose (and tracer) transport and trapping [7]. Figure 1 Relationship between blood glucose concentrations and FDG-PET metrics in two studies.
